When the temperature moves, the evidence must keep up

A temperature alert can arrive with an incomplete story. The logger may be clear while the affected stock list is uncertain; the stock list may be clear while the duration is not. The practical challenge is assembling a dependable record for the appropriately authorised reviewer making the assessment. NEUVIOR’s proposed interest is in that evidence-preparation workflow, with product suitability and stock disposition kept firmly within authorised professional processes.

In development · Intended scope and questions for evaluation

The organisation.
The people around it.

A formulary or service opportunity may depend on local evidence, reliable supply, professional review, delivery resources and a separately authorised commercial arrangement.

The people involved

Manufacturers, marketing-authorisation holders, generic and specialty medicines businesses, suppliers and relevant SMEs.

The dependencies

Medical affairs, market access, regulatory, quality, supply, distribution, procurement and receiving healthcare teams.

What to examine

Source quality, local applicability, implementation requirements, continuity, investment assumptions and the receiving organisation’s priorities.

Explore the ecosystem

An illustrative set of programme relationships. The actual participants, authority, funding and permissions must be established for the defined setting. Explore every organisation perspective.

An alert is the beginning of an investigation

The same headline temperature can mean different things for different products, packaging conditions and exposure histories. A warehouse, courier and receiving pharmacy may each hold part of the record. If those fragments cannot be reconciled, a persuasive summary can be more dangerous than an obviously incomplete one. The useful first task is therefore to identify what is known, what is inferred and which missing information prevents the appropriate reviewer from reaching a supported conclusion.

Use the right professional reference

NHS SPS describes a defined response to temperature excursions, including gathering exposure and product details (NHS SPS, n.d.). Its refrigerated-medicines tool is intended for registered healthcare professionals (NHS SPS, n.d.). These resources do not provide a universal release rule for an industry system. Our proposed evaluation would examine how relevant evidence reaches the authorised reviewer, while preserving product-specific advice, applicable procedures and the organisation’s own quality responsibilities.

Keep the identity attached to the exposure

A proposed record should connect the product, batch where relevant, quantity, location, logger interval and any previous known excursion. It should distinguish a continuous temperature trace from a minimum-and-maximum reading. Time-zone changes, missing intervals and sensor placement can all alter interpretation. The evaluation question is not whether a screen looks complete; it is whether an independent reviewer can reconstruct the information used and recognise where the record remains uncertain.

A record a reviewer can reconstruct

The proposed deliverable would include a source-linked chronology, a product-identity check and a visible list of unresolved information. It would distinguish recorded exposure from assumed exposure and preserve who confirmed each clarification. The reviewer would retain the complete assessment responsibility, with a preparation record that can be checked against the original material.

A retrospective PHARMORIS evaluation

A bounded study could use resolved excursions with approved, de-identified documentation. Inputs would include logger exports, authorised product information, communications and the final qualified assessment. The comparator would be the existing evidence pack. Reviewers could compare the completeness and traceability of a proposed structured brief without allowing it to assess product stability or change live quarantine and release decisions. Cases should include ambiguous records, not only easy examples with clean data.

Measure preparation quality separately

Candidate measures are missing fields recognised, incorrect product or batch associations, reviewer correction time and the ability to find the original supporting record. Review effort should include time spent checking the proposed brief. A shorter preparation stage is not evidence of safe stock release, reduced waste or improved patient access. Those are different outcomes with different evidential requirements. An acceptable evaluation should state exactly which process improvement, if any, was observed.

Boundaries that determine whether to continue

The study would stop if source traces cannot be reconciled, if product-specific advice is used outside its scope, or if experimental output is treated as authority to use medicines. A missing exposure history must remain missing. We would also pause if the comparison penalises a cautious reviewer for appropriately seeking more evidence. The intended value is a clearer assessment record, not pressure to reach a commercially convenient disposition.

A sample handoff, before anyone reaches a disposition

An illustrative deliverable would put the logger interval, consignment identity and warehouse receipt on one chronology. Beside each observation, it would show the source and whether the transport or receiving team confirmed it. A gap between logger stop and receipt would remain an unresolved interval, with a request to the party holding the missing record. The useful output is not a green release symbol. It is a handoff that tells the authorised assessor exactly what can be established and what still prevents assessment.

Repeat the review where the evidence breaks

A quality lead could examine this pattern during an agreed periodic excursion review and whenever a recurring transport or documentation problem emerges. The buyer would provide permitted resolved records, the applicable procedure and an authorised reviewer able to judge preparation quality. Acceptance would require the reviewer to reconstruct the chronology, identify unresolved exposure and locate every supporting record without additional unsupported interpretation. Only a repeated preparation problem that the existing process cannot address efficiently would justify discussing ongoing support.

Start with a recognisable handoff

A distribution quality lead might bring one recurring problem between warehouse and transport records. A manufacturer might bring a repeated request for missing stability context. We can discuss the current workflow, the people authorised to assess it and whether a retrospective comparison is feasible. A disciplined first evaluation could clarify where preparation breaks down and whether better organisation of evidence would help the accountable team, before any broader development or operational use is considered.

Sources and scope

NHS SPS | Managing temperature excursions | NHS SPS | Refrigerated medicines stability tool

NHS SPS (n.d.) Managing temperature excursions. Available at: https://sps.nhs.uk/articles/managing-temperature-excursions/ (Accessed: 14 October 2026).

NHS SPS (n.d.) Refrigerated medicines stability tool. Available at: https://mca.sps.nhs.uk/fridge (Accessed: 14 October 2026).

Bring the question
your organisation
needs to move.

Tell us where the programme gets stuck, who is affected and what a worthwhile evaluation would help you decide.

Discuss a PHARMORIS evaluation

An initial conversation should describe the organisational question. Agree the purpose and information requirements before sharing records.

One programme. A whole system of people.

Original NEUVIOR motion explainer · 36 seconds · no audio. The film illustrates intended scope and questions for evaluation. Read the transcript.